What does APOTHEEK JACOBS do?

APOTHEEK JACOBS is a pharmacy in Lievegem. Public Limited, started on 31 March 1992, 1 establishment.

What is the address of APOTHEEK JACOBS?

The registered office of APOTHEEK JACOBS is located at Stationsstraat 45A, 9950 Lievegem.

Is APOTHEEK JACOBS still active?

Yes. According to the CBE (30 October 2026) APOTHEEK JACOBS is active, legal situation “Normale toestand”, started on 31 March 1992.

Is APOTHEEK JACOBS registered on Peppol?

Yes, APOTHEEK JACOBS is registered on the Peppol network with ID 0208:0447070525.

What is the enterprise number of APOTHEEK JACOBS?

The enterprise number of APOTHEEK JACOBS is BE0447070525.

When was APOTHEEK JACOBS founded?

APOTHEEK JACOBS was founded on 31 March 1992.

Who are the directors of APOTHEEK JACOBS?

According to the 2025 annual accounts, the directors of APOTHEEK JACOBS are: VAN DER HALLEN INVEST.

Is APOTHEEK JACOBS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 31 March 1992; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did APOTHEEK JACOBS make in 2025?

APOTHEEK JACOBS posted a profit after taxes of € 126,905 in financial year 2025.

What is the revenue of APOTHEEK JACOBS?

As a small company, APOTHEEK JACOBS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 232,403.

How much does an employee at APOTHEEK JACOBS earn?

The average wage cost per full-time employee at APOTHEEK JACOBS was € 39,200 in 2025: staff costs of € 39,223 for 1 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK JACOBS have?

According to the 2025 annual accounts, APOTHEEK JACOBS has 1 full-time equivalents (FTE).

APOTHEEK JACOBS (Public Limited) - Lievegem

Dossier APOTHEEK JACOBS, printed on 30 October 2026 from databakkes.be/en/0447070525/apotheek-jacobs. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK JACOBS from Lievegem, company number BE0447070525, closed financial year 2025 with a result of € 126,905 after tax. For that financial year APOTHEEK JACOBS recorded a gross margin of € 232,403 and equity of € 475,538. Compared with financial year 2024, the result moved from € 129,117 to € 126,905. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 2, 2026.

What it is worth Healthy

€ 475,538

▼ 4% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 126,905

▼ 2% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 216,178

▲ 17% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 145,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 39,223

▲ 7% vs 2024

€ 39,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt ≈ 7 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 211,667

▼ 12% vs 2024

€ 30,000 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.

Owed to suppliers

€ 69,757

▲ 1% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 5,802

▼ 31% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 65,589 Gross margin 2022: € 65,589 First fiscal year in the series	€ 176,821 Gross margin 2023: € 176,821 ▲ 170% vs 2022 (€ 65,589) Favourable step	€ 234,732 Gross margin 2024: € 234,732 ▲ 33% vs 2023 (€ 176,821) Favourable step	€ 232,403 Gross margin 2025: € 232,403 ▼ 1% vs 2024 (€ 234,732) Unfavourable step	▼ 1%
Profit after taxes	€ -3,117 Profit after taxes 2022: € -3,117 First fiscal year in the series	€ 84,037 Profit after taxes 2023: € 84,037 ▲ € 87,154 vs 2022 (€ -3,117) Favourable step	€ 129,117 Profit after taxes 2024: € 129,117 ▲ 54% vs 2023 (€ 84,037) Favourable step	€ 126,905 Profit after taxes 2025: € 126,905 ▼ 2% vs 2024 (€ 129,117) Unfavourable step	▼ 2%
Equity	€ 506,479 Equity 2022: € 506,479 First fiscal year in the series	€ 509,516 Equity 2023: € 509,516 ▲ 1% vs 2022 (€ 506,479) Favourable step	€ 493,633 Equity 2024: € 493,633 ▼ 3% vs 2023 (€ 509,516) Unfavourable step	€ 475,538 Equity 2025: € 475,538 ▼ 4% vs 2024 (€ 493,633) Unfavourable step	▼ 4%
Total debts	€ 184,816 Total debts 2022: € 184,816 First fiscal year in the series	€ 422,291 Total debts 2023: € 422,291 ▲ 128% vs 2022 (€ 184,816) Unfavourable step	€ 464,665 Total debts 2024: € 464,665 ▲ 10% vs 2023 (€ 422,291) Unfavourable step	€ 432,704 Total debts 2025: € 432,704 ▼ 7% vs 2024 (€ 464,665) Favourable step	▼ 7%
Cash	€ 166,654 Cash 2022: € 166,654 First fiscal year in the series	€ 214,549 Cash 2023: € 214,549 ▲ 29% vs 2022 (€ 166,654) Favourable step	€ 185,339 Cash 2024: € 185,339 ▼ 14% vs 2023 (€ 214,549) Unfavourable step	€ 216,178 Cash 2025: € 216,178 ▲ 17% vs 2024 (€ 185,339) Favourable step	▲ 17%
Retained profit	€ 444,479 Retained profit 2022: € 444,479 First fiscal year in the series	€ 447,516 Retained profit 2023: € 447,516 ▲ 1% vs 2022 (€ 444,479) Favourable step	€ 431,633 Retained profit 2024: € 431,633 ▼ 4% vs 2023 (€ 447,516) Unfavourable step	€ 413,538 Retained profit 2025: € 413,538 ▼ 4% vs 2024 (€ 431,633) Unfavourable step	▼ 4%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 81,000 Dividend 2023: € 81,000 Unchanged (€ 0) Unchanged	€ 145,000 Dividend 2024: € 145,000 ▲ 79% vs 2023 (€ 81,000) Unchanged	€ 145,000 Dividend 2025: € 145,000 Unchanged (€ 145,000) Unchanged
Bank debt	€ 103,067 Bank debt 2022: € 103,067 First fiscal year in the series	€ 278,794 Bank debt 2023: € 278,794 ▲ 170% vs 2022 (€ 103,067) Unfavourable step	€ 241,667 Bank debt 2024: € 241,667 ▼ 13% vs 2023 (€ 278,794) Favourable step	€ 211,667 Bank debt 2025: € 211,667 ▼ 12% vs 2024 (€ 241,667) Favourable step	▼ 12%
Balance sheet total	€ 736,242 Balance sheet total 2022: € 736,242 First fiscal year in the series	€ 970,180 Balance sheet total 2023: € 970,180 ▲ 32% vs 2022 (€ 736,242) Unchanged	€ 990,098 Balance sheet total 2024: € 990,098 ▲ 2% vs 2023 (€ 970,180) Unchanged	€ 933,467 Balance sheet total 2025: € 933,467 ▼ 6% vs 2024 (€ 990,098) Unchanged	▼ 6%
Employees (FTE)	1 Employees (FTE) 2022: 1 First fiscal year in the series	1 Employees (FTE) 2023: 1 Unchanged (1) Unchanged	1 Employees (FTE) 2024: 1 Unchanged (1) Unchanged	1 Employees (FTE) 2025: 1 Unchanged (1) Unchanged

Key figures of APOTHEEK JACOBS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK JACOBS?

What happened at APOTHEEK JACOBS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 2, 2026 New annual accounts for financial year 2025: profit of € 126,905 (▼ 2% vs 2024). Source: NBB ↗
2012 VAN DER HALLEN INVEST became a director. NBB
May 13, 1992 New establishment in Lievegem. KBO
Mar 31, 1992 Start of the company according to the CBE. KBO

In short

From € 3,117 loss in 2022 to € 126,905 profit in 2025.

Paid € 3,586 in corporate taxes since 2022.

Best year ever: 2024, with € 129,117 profit.

On average € 232,400 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

VAN DER HALLEN INVEST 99.2%

The stake of VAN DER HALLEN INVEST comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK JACOBS

Behind APOTHEEK JACOBS is VAN DER HALLEN INVEST. The shares are held by VAN DER HALLEN INVEST (99.2%).

Directors

According to the 2025 annual accounts

VAN DER HALLEN INVEST

Director · represented by Dieter Van Der Hallen

since 2012

Shareholders

VAN DER HALLEN INVEST

99.2%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Stationsstraat 45A

9950 Lievegem

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0447.070.525

VAT number

BE 0447.070.525

Registered office

Stationsstraat 45A, 9950 Lievegem

Names & denominations

APOTHEEK JACOBS · APOTHEEK JACOBS NV

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

31 March 1992

Peppol

Active · Active since 3 Jul 2025

Contact

[email protected]

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗